VENUSREMPharmaceuticals
Venus Remedies Ltd — PE Ratio & Valuation Analysis
₹820.05
-1.79%
Current P/E15.33xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E15.5x1.1% below avg
✅
51.7% Discount to Industry
VENUSREM P/E 15.33x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹33.90 | ₹766 | 22.6x |
| 2024 | ₹21.31 | ₹318 | 14.9x |
| 2023 | ₹19.88 | ₹406 | 20.4x |
| 2022 | ₹30.86 | ₹128 | 4.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Venus Remedies Ltd Valuation
Venus Remedies Ltd (VENUSREM) currently trades at 15.33x earnings. The Pharmaceuticals sector average PE is 31.77x. VENUSREM is trading at a discount to peers — may indicate relative value. Historically, VENUSREM has traded at an average PE of 15.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
7.16%
Dividend Yield
0.00%
More on Venus Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.